UFP-101
UFP-101 is a selective nociceptin receptor antagonist that has been used in scientific research to study the role of the nociceptin/orphanin FQ peptide (NOP) receptor in various physiological and pathological processes.
Pharmacology[edit | edit source]
UFP-101 is a peptide-based compound that acts as a competitive antagonist at the NOP receptor, which is a member of the opioid receptor family. Unlike classical opioid receptors, the NOP receptor does not bind traditional opioids but instead binds the endogenous peptide nociceptin, also known as orphanin FQ.
Mechanism of Action[edit | edit source]
UFP-101 binds to the NOP receptor and inhibits the action of nociceptin, thereby blocking the downstream signaling pathways that are typically activated by this peptide. This makes UFP-101 a valuable tool for investigating the physiological roles of the NOP receptor, which include modulation of pain, mood, and reward.
Research Applications[edit | edit source]
UFP-101 has been used in various animal models to explore the potential therapeutic applications of NOP receptor modulation. Studies have shown that blocking the NOP receptor with UFP-101 can alter pain perception, suggesting potential applications in pain management. Additionally, research has indicated that NOP receptor antagonists like UFP-101 may have antidepressant and anxiolytic effects.
Chemical Properties[edit | edit source]
UFP-101 is a synthetic peptide with a specific sequence designed to selectively bind to the NOP receptor. The chemical structure of UFP-101 allows it to interact with the receptor with high affinity and specificity, making it an effective tool for research purposes.
Safety and Toxicology[edit | edit source]
As a research chemical, UFP-101 is not approved for human use and is primarily used in laboratory settings. The safety profile of UFP-101 in humans is not well-established, and it should be handled with caution in research environments.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
